Senate Bill 3161
116th Congress(2019-2020)
National Biomedical Research Act
Introduced
Introduced in Senate on Jan 8, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3161
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
National Biomedical Research Act
This bill establishes and makes deposits through FY2029 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative research.
January 8, 2020
01/08/2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
01/08/2020
Introduced in Senate
Public Record
Record Updated
Feb 8, 2022 11:22:51 PM